$AQST
Aquestive Therapeutics, Inc. Stock $aqst

$aqst Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000162828023010180 Filed on March 31, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$11.13M	$10.68M	$47.68M
YoY Change	-9.26%	-3.57%	-6.2%
Cost Of Revenue	$4.737M	$5.305M	$19.39M
YoY Change	12.41%	57.61%	29.33%
Gross Profit	$6.397M	$5.377M	$28.29M
YoY Change	-20.59%	-30.28%	-21.06%
Gross Profit Margin	57.45%	50.34%	59.34%
Selling, General & Admin	$7.455M	$11.81M	$52.88M
YoY Change	-42.75%	-21.15%	-1.11%
% of Gross Profit	116.54%	219.68%	186.89%
Research & Development	$3.547M	$4.278M	$17.48M
YoY Change	-25.69%	-2.77%	2.55%
% of Gross Profit	55.45%	79.56%	61.78%
Depreciation & Amortization	$286.0K	$397.0K	$2.270M
YoY Change	-59.94%	-45.69%	-22.05%
% of Gross Profit	4.47%	7.38%	8.02%
Operating Expenses	$11.00M	$16.09M	$70.36M
YoY Change	-38.17%	-16.98%	-17.72%
Operating Profit	-$4.605M	-$10.71M	-$42.07M
YoY Change	-52.71%	-8.19%	21.3%
Interest Expense	$1.435M	-$1.639M	-$12.34M
YoY Change	-11.31%	-52.55%	-222.84%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$8.068M	-$12.35M	-$54.41M
YoY Change	-161.03%	-57.33%	-22.87%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income	0.0%
Net Earnings	$8.068M	-$12.35M	-$54.41M
YoY Change	-161.03%	-57.33%	-22.87%
Net Earnings / Revenue	72.46%	-115.63%	-114.11%
Basic Earnings Per Share	$0.15		-$1.12
Diluted Earnings Per Share	$0.11	-$0.23	-$1.12
COMMON SHARES
Basic Shares Outstanding	55.87M shares	54.16M shares	48.73M shares
Diluted Shares Outstanding	73.79M shares		48.73M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$26.88M	$27.27M	$27.27M
YoY Change	82.42%	-2.68%	-2.68%
Cash & Equivalents	$26.88M	$27.27M	$27.27M
Short-Term Investments
Other Short-Term Assets	$2.292M	$2.131M	$2.131M
YoY Change	-31.05%	-30.74%	-30.74%
Inventory	$6.981M	$5.780M	$5.780M
Prepaid Expenses
Receivables	$7.551M	$4.704M	$4.704M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$43.71M	$39.89M	$39.89M
YoY Change	2.63%	-15.6%	-15.6%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.814M	$7.901M	$7.901M
YoY Change	-15.17%	56.3%	1.56%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$6.485M	$6.451M	$6.451M
YoY Change	-5.82%	-6.55%	614.4%
Total Long-Term Assets	$17.58M	$15.79M	$15.79M
YoY Change	26.07%	7.15%	7.15%
TOTAL ASSETS
Total Short-Term Assets	$43.71M	$39.89M	$39.89M
Total Long-Term Assets	$17.58M	$15.79M	$15.79M
Total Assets	$61.29M	$55.68M	$55.68M
YoY Change	8.41%	-10.19%	-10.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$12.44M	$9.946M	$9.946M
YoY Change	46.42%	19.63%	19.63%
Accrued Expenses	$4.508M	$8.373M	$8.373M
YoY Change	-7.4%	-4.16%	-13.1%
Deferred Revenue	$4.765M	$1.513M
YoY Change	198.0%	97.78%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$17.20M	$18.70M	$18.70M
YoY Change	162.0%	823.46%	823.46%
Total Short-Term Liabilities	$40.38M	$39.68M	$39.68M
YoY Change	66.98%	80.65%	80.65%
LONG-TERM LIABILITIES
Long-Term Debt	$25.20M	$33.45M	$33.45M
YoY Change	-47.16%	-35.12%	-35.12%
Other Long-Term Liabilities	$2.059M	$101.1M	$101.1M
YoY Change	10.58%	3968.49%	43.18%
Total Long-Term Liabilities	$2.059M	$134.6M	$134.6M
YoY Change	10.58%	5314.49%	10.14%
TOTAL LIABILITIES
Total Short-Term Liabilities	$40.38M	$39.68M	$39.68M
Total Long-Term Liabilities	$2.059M	$134.6M	$134.6M
Total Liabilities	$170.5M	$174.2M	$174.2M
YoY Change	13.93%	20.89%	20.89%
SHAREHOLDERS EQUITY
Retained Earnings	-$303.1M	-$311.2M
YoY Change	12.27%	21.19%
Common Stock	$56.00K	$55.00K
YoY Change	36.59%	34.15%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$109.2M	-$118.6M	-$118.6M
YoY Change
Total Liabilities & Shareholders Equity	$61.29M	$55.68M	$55.68M
YoY Change	8.41%	-10.19%	-10.19%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	$8.068M	-$12.35M	-$54.41M
YoY Change	-161.03%	-57.33%	-22.87%
Depreciation, Depletion And Amortization	$286.0K	$397.0K	$2.270M
YoY Change	-59.94%	-45.69%	-22.05%
Cash From Operating Activities	$8.816M	$8.446M	-$9.789M
YoY Change	-160.88%	-204.78%	-70.32%
INVESTING ACTIVITIES
Capital Expenditures	$2.000K	$26.00K	$1.024M
YoY Change	-98.08%	-104.88%	12.16%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$2.000K	-$26.00K	-$2.524M
YoY Change	-98.08%	-95.12%	176.45%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$9.205M	204.0K	$11.56M
YoY Change	-809.17%	-96.26%	-61.6%
NET CHANGE
Cash From Operating Activities	$8.816M	8.446M	-$9.789M
Cash From Investing Activities	-$2.000K	-26.00K	-$2.524M
Cash From Financing Activities	-$9.205M	204.0K	$11.56M
Net Change In Cash	-$391.0K	8.624M	-$751.0K
YoY Change	-97.06%	-374.65%	-80.15%
FREE CASH FLOW
Cash From Operating Activities	$8.816M	$8.446M	-$9.789M
Capital Expenditures	$2.000K	$26.00K	$1.024M
Free Cash Flow	$8.814M	$8.420M	-$10.81M
YoY Change	-160.43%	-211.85%	-68.1%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001398733
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	27600000	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	55870556	shares
CY2022	dei	Auditor Firm AuditorFirmId	185
CY2022	dei	Auditor Name AuditorName	KPMG LLP
CY2022	dei	Auditor Location AuditorLocation	New York, New York
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	27273000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28024000	usd
CY2022Q4	aqst	Trade And Other Receivables Net TradeAndOtherReceivablesNet	4704000	usd
CY2021Q4	aqst	Trade And Other Receivables Net TradeAndOtherReceivablesNet	12120000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	5780000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	4038000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2131000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3077000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	39888000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	47259000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4085000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5055000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5211000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2725000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1435000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	51000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6451000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6903000	usd
CY2022Q4	us-gaap	Assets Assets	57070000	usd
CY2021Q4	us-gaap	Assets Assets	61993000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	9946000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	8314000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7967000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8736000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	255000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	899000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1513000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	765000	usd
CY2022Q4	aqst	Transfer Of Financial Assets Accounted For As Sales Amount Derecognized Current TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedCurrent	1147000	usd
CY2021Q4	aqst	Transfer Of Financial Assets Accounted For As Sales Amount Derecognized Current TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedCurrent	1225000	usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	18700000	usd
CY2021Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	2025000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	39528000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	21964000	usd
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	33448000	usd
CY2021Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	51551000	usd
CY2022Q4	aqst	Liabilities Sale Of Future Revenue Net LiabilitiesSaleOfFutureRevenueNet	64112000	usd
CY2021Q4	aqst	Liabilities Sale Of Future Revenue Net LiabilitiesSaleOfFutureRevenueNet	59059000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5085000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1946000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	31417000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	7122000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2034000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2485000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	175624000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	144127000	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	54827734	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	54827734	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41228736	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41228736	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	55000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	41000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	192598000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	174621000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-311207000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-256796000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-118554000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-82134000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	57070000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	61993000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	47680000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	50832000	usd
CY2022	aqst	Manufacture And Supply Costs ManufactureAndSupplyCosts	19386000	usd
CY2021	aqst	Manufacture And Supply Costs ManufactureAndSupplyCosts	14989000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	89746000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	85511000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-42066000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-34679000	usd
CY2022	us-gaap	Interest Expense InterestExpense	6552000	usd
CY2021	us-gaap	Interest Expense InterestExpense	10049000	usd
CY2022	aqst	Interest Expense Sale Of Future Revenues InterestExpenseSaleOfFutureRevenues	5891000	usd
CY2021	aqst	Interest Expense Sale Of Future Revenues InterestExpenseSaleOfFutureRevenues	12412000	usd
CY2022	us-gaap	Interest And Other Income InterestAndOtherIncome	99000	usd
CY2021	us-gaap	Interest And Other Income InterestAndOtherIncome	423000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-54410000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-70539000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-54410000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-70539000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-54410000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-70539000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.12
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.12
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.85
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.85
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48734377	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48734377	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38077660	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	38077660	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-48497000	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	31069000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Ownshare Lending Arrangement Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts	-1291000	usd
CY2021	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	158000	usd
CY2021	aqst	Apic Share Based Payment Arrangement Exercise Of Stock Options APICShareBasedPaymentArrangementExerciseOfStockOptions	185000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	-14000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6795000	usd
CY2022	aqst	Adjustments To Additional Paid In Capital Fair Value Of Warrants Issued AdjustmentsToAdditionalPaidInCapitalFairValueOfWarrantsIssued	5874000	usd
CY2022	aqst	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	0	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4196000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Ownshare Lending Arrangement Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts	-289000	usd
CY2022	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	34000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	-3000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4371000	usd
CY2022	us-gaap	Stockholders Equity Other StockholdersEquityOther	-2000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-54410000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-118554000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-54410000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-70539000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2387000	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2964000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	4381000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	6819000	usd
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	215000	usd
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	3731000	usd
CY2022	aqst	Interest Expense Sale Of Future Revenues Excluding Amortization InterestExpenseSaleOfFutureRevenuesExcludingAmortization	5683000	usd
CY2021	aqst	Interest Expense Sale Of Future Revenues Excluding Amortization InterestExpenseSaleOfFutureRevenuesExcludingAmortization	12253000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-13822000	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	52000	usd
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	299000	usd
CY2022	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-7352000	usd
CY2021	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	5353000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1743000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1577000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1399000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1258000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1633000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1225000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-2352000	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-844000	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	25043000	usd
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	3561000	usd
CY2022	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	675000	usd
CY2021	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	0	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9789000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-32979000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1024000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	913000	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1500000	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2524000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-913000	usd
CY2022	aqst	Proceeds From Issuance Of Public Offering Issuance Of Warrants And Warrant Exercises ProceedsFromIssuanceOfPublicOfferingIssuanceOfWarrantsAndWarrantExercises	9751000	usd
CY2021	aqst	Proceeds From Issuance Of Public Offering Issuance Of Warrants And Warrant Exercises ProceedsFromIssuanceOfPublicOfferingIssuanceOfWarrantsAndWarrantExercises	29780000	usd
CY2022	aqst	Proceeds From Issuance Private Offering ProceedsFromIssuancePrivateOffering	3805000	usd
CY2021	aqst	Proceeds From Issuance Private Offering ProceedsFromIssuancePrivateOffering	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	34000	usd
CY2021	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	158000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	185000	usd
CY2022	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	2025000	usd
CY2021	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	3000	usd
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	14000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	11562000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	30109000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-751000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3783000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28024000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	31807000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	27273000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28024000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	6436000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	6438000	usd
CY2022Q4	aqst	Number Of Licensed Commercialized Products NumberOfLicensedCommercializedProducts	5	licensedcommercializedproduct
CY2022	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Ownshare Lending Arrangement Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts	-289000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Ownshare Lending Arrangement Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts	-1291000	usd
CY2022Q2	aqst	Ownership Limitation Maximum Percent Of Beneficial Ownership OwnershipLimitationMaximumPercentOfBeneficialOwnership	0.0999
CY2022	us-gaap	Basis Of Accounting BasisOfAccounting	Basis of Presentation and Principles of Consolidation<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">These consolidated financial statements have been prepared in accordance with Generally Accepted Accounting Principles ("GAAP") in the United States of America, and in accordance with the rules and regulations of the Securities and Exchange Commission ("SEC"). The accounts of wholly owned subsidiaries are included in the consolidated financial statements. Other than corporate formation activities, no such subsidiaries have conducted any commercial, developmental or operational activities and none have customers or vendors. Certain reclassifications were made to conform to the current presentation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Any reference in these notes to applicable guidance is meant to refer to the authoritative United States generally accepted principles as found in the Accounting Standards Codification (“ASC”) and Accounting Standards Updates (“ASU”) of the Financial Accounting Standards Board (“FASB”).</span></div>
CY2022	us-gaap	Use Of Estimates UseOfEstimates	Use of EstimatesThe preparation of financial statements in conformity with U.S. GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, including disclosure of contingent assets and contingent liabilities, at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates and assumptions often involve assessments of matters that are inherently uncertain and accordingly actual results could differ from those estimates. Significant items subject to estimates and assumptions include those related to revenue recognition, inventory costs, allowances for rebates from proprietary product sales, allowances for sales returns, the useful lives of fixed assets, the valuations of warrants issued and of share-based compensation, and contingencies.
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	Concentration of Credit RiskCash and cash equivalents are maintained are held by federally insured financial institutions that management believes are of high credit quality. The Company has not experienced any losses in such accounts and such amounts may exceed federally-insured limits of $250.
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	40000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	40000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	40000	usd
CY2022Q4	aqst	Accounts Receivable Allowances And Accruals Trade And Other Receivables Net AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet	669000	usd
CY2021Q4	aqst	Accounts Receivable Allowances And Accruals Trade And Other Receivables Net AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet	605000	usd
CY2022Q4	aqst	Trade And Other Receivables Net TradeAndOtherReceivablesNet	4704000	usd
CY2021Q4	aqst	Trade And Other Receivables Net TradeAndOtherReceivablesNet	12120000	usd
CY2022	aqst	Research And Development Project Duration ResearchAndDevelopmentProjectDuration	P3Y
CY2022Q4	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	2139000	usd
CY2021Q4	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	3087000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	40000	usd
CY2019Q3	aqst	Net Proceeds From Issuance Of Initial Notes Warrants And First Offer Rights NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights	66082000	usd
CY2020Q4	aqst	Number Of Transactions NumberOfTransactions	2	vestingperiod
CY2020Q4	aqst	Premiums Paid Early Retirement Of Debt PremiumsPaidEarlyRetirementOfDebt	2250000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	27273000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-311207000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Ownshare Lending Arrangement Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts	-289000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	47680000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	50832000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	47680000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	50832000	usd
CY2022Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	3274000	usd
CY2021Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	9678000	usd
CY2022Q4	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	2139000	usd
CY2021Q4	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	3087000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	40000	usd
CY2021Q4	aqst	Accounts Receivable Allowances And Accruals AccountsReceivableAllowancesAndAccruals	605000	usd
CY2020Q4	aqst	Accounts Receivable Allowances And Accruals AccountsReceivableAllowancesAndAccruals	416000	usd
CY2022	aqst	Accounts Receivable Allowances Provision Related To Sales AccountsReceivableAllowancesProvisionRelatedToSales	1365000	usd
CY2021	aqst	Accounts Receivable Allowances Provision Related To Sales AccountsReceivableAllowancesProvisionRelatedToSales	1209000	usd
CY2022	aqst	Accounts Receivable Allowances Credits And Payments AccountsReceivableAllowancesCreditsAndPayments	1301000	usd
CY2021	aqst	Accounts Receivable Allowances Credits And Payments AccountsReceivableAllowancesCreditsAndPayments	1020000	usd
CY2022Q4	aqst	Accounts Receivable Allowances And Accruals AccountsReceivableAllowancesAndAccruals	669000	usd
CY2021Q4	aqst	Accounts Receivable Allowances And Accruals AccountsReceivableAllowancesAndAccruals	605000	usd
CY2022Q2	aqst	Pro Rata Portion Of Target Bonus ProRataPortionOfTargetBonus	280000	usd
CY2022Q2	aqst	Cash Payment Representing90 Days Of Base Pay CashPaymentRepresenting90DaysOfBasePay	150000	usd
CY2022Q2	aqst	Days Of Base Pay DaysOfBasePay	90	day
CY2022Q2	us-gaap	Severance Costs1 SeveranceCosts1	263000	usd
CY2022Q2	aqst	Number Of Installments NumberOfInstallments	3	vestingperiod
CY2022Q2	aqst	Severance Period SeverancePeriod	P18M
CY2022Q2	aqst	Coverage Duration CoverageDuration	P18M
CY2022Q2	aqst	Consulting Fee ConsultingFee	10000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1899000	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1442000	usd
CY2022Q4	aqst	Inventory Packing Material Gross InventoryPackingMaterialGross	2914000	usd
CY2021Q4	aqst	Inventory Packing Material Gross InventoryPackingMaterialGross	1414000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	967000	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1182000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	5780000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	4038000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	322000	usd
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	349000	usd
CY2022Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	1012000	usd
CY2021Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	2224000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	244000	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	198000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7967000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8736000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	46048000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	44915000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	41963000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	39860000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4085000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5055000	usd
CY2022	us-gaap	Depreciation Depreciation	2270000	usd
CY2021	us-gaap	Depreciation Depreciation	2912000	usd
CY2022	aqst	Number Of Leases NumberOfLeases	3	lease
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	1753000	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	1725000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	449000	usd
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	469000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1050000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1006000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1034000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1060000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1079000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	4927000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	10156000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	4816000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	5340000	usd
CY2019Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	2000000	shares
CY2019Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.001
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	4367000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2867000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2932000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2816000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1435000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	51000	usd
CY2022Q4	aqst	Royalty Receivable RoyaltyReceivable	5000000	usd
CY2021Q4	aqst	Royalty Receivable RoyaltyReceivable	6000000	usd
CY2022Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	1451000	usd
CY2021Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	903000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6451000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6903000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	116000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	51000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	156000	usd
CY2020Q2	aqst	Number Of1000 Annual Minimum Guaranteed Royalties NumberOf1000AnnualMinimumGuaranteedRoyalties	5	minimumguaranteedroyalty
CY2020Q2	aqst	Minimum Annual Royalty Receivable MinimumAnnualRoyaltyReceivable	1000000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6389000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5965000	usd
CY2020Q4	aqst	Premiums Paid Early Retirement Of Debt PremiumsPaidEarlyRetirementOfDebt	2250000	usd
CY2022	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	675000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	18025000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	21888000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	11587000	usd
CY2021	aqst	Class Of Warrant Or Right Warrants Exercised ClassOfWarrantOrRightWarrantsExercised	0	shares
CY2022	aqst	Class Of Warrant Or Right Warrants Exercised ClassOfWarrantOrRightWarrantsExercised	0	shares
CY2022Q2	aqst	Adjustments To Additional Paid In Capital Fair Value Of Warrants Issued AdjustmentsToAdditionalPaidInCapitalFairValueOfWarrantsIssued	5874000	usd
CY2020Q4	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	2909000	usd
CY2020Q2	aqst	Minimum Annual Royalty Receivable MinimumAnnualRoyaltyReceivable	1000000	usd
CY2021Q4	aqst	Liabilities Sale Of Future Royalties LiabilitiesSaleOfFutureRoyalties	60284000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	208000	usd
CY2022	aqst	Interest Expense Sale Of Future Revenues Excluding Amortization InterestExpenseSaleOfFutureRevenuesExcludingAmortization	5683000	usd
CY2022Q4	aqst	Liabilities Sale Of Future Royalties Current LiabilitiesSaleOfFutureRoyaltiesCurrent	1147000	usd
CY2022Q4	aqst	Liabilities Sale Of Future Royalties LiabilitiesSaleOfFutureRoyalties	65259000	usd
CY2021Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	1712000	usd
CY2022	aqst	Asset Retirement Obligations Depreciation Expense AssetRetirementObligationsDepreciationExpense	25000	usd
CY2021	aqst	Asset Retirement Obligations Depreciation Expense AssetRetirementObligationsDepreciationExpense	23000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6819000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4381000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6819000	usd
CY2020Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	1525000	usd
CY2021	us-gaap	Asset Retirement Obligation Liabilities Incurred AssetRetirementObligationLiabilitiesIncurred	0	usd
CY2021	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	187000	usd
CY2021Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	1712000	usd
CY2022	us-gaap	Asset Retirement Obligation Liabilities Incurred AssetRetirementObligationLiabilitiesIncurred	110000	usd
CY2022	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	167000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-54410000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-70539000	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48734377	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48734377	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	38077660	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38077660	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.12
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.12
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.85
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.85
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	400000	shares
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4381000	usd
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3259000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.14
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y5M1D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	2978000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1212000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	4.73
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	264000	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	7.52
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	61000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4146000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.28
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y10M17D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	1423000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2015000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.83
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	133000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	7.81
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6028000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.48
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y6M
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	38000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	5877000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	5.57
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P7Y5M15D
CY2022Q4	aqst	Share Based Compensation Arrangement By Share Based Payment Award Options Vested Or Expected To Vest Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOrExpectedToVestAggregateIntrinsicValue	36000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3652000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	7.42
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P6Y6M25D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	0	usd
CY2022Q4	us-gaap	Share Price SharePrice	0.90
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	84312000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	73351000	usd
CY2022Q4	aqst	Deferred Tax Liabilities481a Adjustment DeferredTaxLiabilities481aAdjustment	0	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y6M
CY2022	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	815000	usd
CY2021	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	706000	usd
CY2022Q4	aqst	Deferred Tax Assets Accounts Receivable DeferredTaxAssetsAccountsReceivable	177000	usd
CY2021Q4	aqst	Deferred Tax Assets Accounts Receivable DeferredTaxAssetsAccountsReceivable	149000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	449000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	100000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	1063000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	309000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	32197000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	28722000	usd
CY2022Q4	aqst	Tax Cuts And Jobs Act Of2017 Deferred Tax Assets Interest Limitation TaxCutsAndJobsActOf2017DeferredTaxAssetsInterestLimitation	10667000	usd
CY2021Q4	aqst	Tax Cuts And Jobs Act Of2017 Deferred Tax Assets Interest Limitation TaxCutsAndJobsActOf2017DeferredTaxAssetsInterestLimitation	9022000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	5813000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	5003000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2408000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2122000	usd
CY2022Q4	aqst	Deferred Tax Assets Sale Of Future Revenue DeferredTaxAssetsSaleOfFutureRevenue	17139000	usd
CY2021Q4	aqst	Deferred Tax Assets Sale Of Future Revenue DeferredTaxAssetsSaleOfFutureRevenue	16595000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	2576000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	2566000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	5625000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	5490000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	697000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	726000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	1731000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	2547000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	3770000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	0	usd
CY2021Q4	aqst	Deferred Tax Liabilities481a Adjustment DeferredTaxLiabilities481aAdjustment	14000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	524000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	807000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	524000	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	821000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	83788000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	72530000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	83788000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	72530000	usd
CY2022Q4	aqst	Research And Development Costs Capitalized ResearchAndDevelopmentCostsCapitalized	16560000	usd
CY2022Q4	aqst	Number Of Uncertain Tax Positions NumberOfUncertainTaxPositions	0	taxposition
CY2021Q4	aqst	Number Of Uncertain Tax Positions NumberOfUncertainTaxPositions	0	taxposition
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0423
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0528
CY2022	aqst	Effective Income Tax Rate Reconciliation Permanent Differences Percent EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent	-0.0020
CY2021	aqst	Effective Income Tax Rate Reconciliation Permanent Differences Percent EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent	-0.0015
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.0020
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.0012
CY2022	aqst	Effective Income Tax Rate Reconciliation Tax Credit Return To Provision Percent EffectiveIncomeTaxRateReconciliationTaxCreditReturnToProvisionPercent	0.0011
CY2021	aqst	Effective Income Tax Rate Reconciliation Tax Credit Return To Provision Percent EffectiveIncomeTaxRateReconciliationTaxCreditReturnToProvisionPercent	-0.0063
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.2069
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.2237
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.0467
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.0263
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.0074
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0002
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0012
CY2016Q3	aqst	Number Of States That Brought A Lawsuit NumberOfStatesThatBroughtALawsuit	41	state

Files In Submission

Name	View Source	Status
aqst-20221231_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
aqst-20221231_cal.xml	Edgar Link	unprocessable
aqst-20221231_pre.xml	Edgar Link	unprocessable
aqst-20221231_lab.xml	Edgar Link	unprocessable
0001628280-23-010180-index-headers.html	Edgar Link	pending
0001628280-23-010180-index.html	Edgar Link	pending
0001628280-23-010180.txt	Edgar Link	pending
0001628280-23-010180-xbrl.zip	Edgar Link	pending
amend1purchaseagreement.htm	Edgar Link	pending
amend1purchaseagreement001.jpg	Edgar Link	pending
amend1purchaseagreement002.jpg	Edgar Link	pending
amend1purchaseagreement003.jpg	Edgar Link	pending
amend1purchaseagreement004.jpg	Edgar Link	pending
amend1purchaseagreement005.jpg	Edgar Link	pending
amend1purchaseagreement006.jpg	Edgar Link	pending
amend1purchaseagreement007.jpg	Edgar Link	pending
amend1purchaseagreement008.jpg	Edgar Link	pending
amend1purchaseagreement009.jpg	Edgar Link	pending
aqst-12312022xexhibit311.htm	Edgar Link	pending
aqst-12312022xexhibit312.htm	Edgar Link	pending
aqst-12312022xexhibit321.htm	Edgar Link	pending
aqst-12312022xexhibit322.htm	Edgar Link	pending
aqst-20221231.htm	Edgar Link	pending
aqst-20221231.xsd	Edgar Link	pending
aqst-20221231_g1.jpg	Edgar Link	pending
aqst-20221231_g2.jpg	Edgar Link	pending
aqst-assertiolicenseagre.htm	Edgar Link	pending
aqst-assertiolicenseagre001.jpg	Edgar Link	pending
aqst-assertiolicenseagre002.jpg	Edgar Link	pending
aqst-assertiolicenseagre003.jpg	Edgar Link	pending
aqst-assertiolicenseagre004.jpg	Edgar Link	pending
aqst-assertiolicenseagre005.jpg	Edgar Link	pending
aqst-assertiolicenseagre006.jpg	Edgar Link	pending
aqst-assertiolicenseagre007.jpg	Edgar Link	pending
aqst-assertiolicenseagre008.jpg	Edgar Link	pending
aqst-assertiolicenseagre009.jpg	Edgar Link	pending
aqst-assertiolicenseagre010.jpg	Edgar Link	pending
aqst-assertiolicenseagre011.jpg	Edgar Link	pending
aqst-assertiolicenseagre012.jpg	Edgar Link	pending
aqst-assertiolicenseagre013.jpg	Edgar Link	pending
aqst-assertiolicenseagre014.jpg	Edgar Link	pending
aqst-assertiolicenseagre015.jpg	Edgar Link	pending
aqst-assertiolicenseagre016.jpg	Edgar Link	pending
aqst-20221231_htm.xml	Edgar Link	completed
aqst-assertiolicenseagre017.jpg	Edgar Link	pending
aqst-assertiolicenseagre018.jpg	Edgar Link	pending
aqst-assertiolicenseagre019.jpg	Edgar Link	pending
aqst-assertiolicenseagre020.jpg	Edgar Link	pending
aqst-assertiolicenseagre021.jpg	Edgar Link	pending
aqst-assertiolicenseagre022.jpg	Edgar Link	pending
aqst-assertiolicenseagre023.jpg	Edgar Link	pending
aqst-assertiolicenseagre024.jpg	Edgar Link	pending
aqst-assertiolicenseagre025.jpg	Edgar Link	pending
aqst-assertiolicenseagre026.jpg	Edgar Link	pending
aqst-assertiolicenseagre027.jpg	Edgar Link	pending
aqst-assertiolicenseagre028.jpg	Edgar Link	pending
aqst-assertiolicenseagre029.jpg	Edgar Link	pending
aqst-assertiolicenseagre030.jpg	Edgar Link	pending
aqst-assertiolicenseagre031.jpg	Edgar Link	pending
aqst-assertiolicenseagre032.jpg	Edgar Link	pending
aqst-assertiolicenseagre033.jpg	Edgar Link	pending
aqst-assertiolicenseagre034.jpg	Edgar Link	pending
aqst-assertiolicenseagre035.jpg	Edgar Link	pending
aqst-assertiolicenseagre036.jpg	Edgar Link	pending
aqst-assertiolicenseagre037.jpg	Edgar Link	pending
aqst-assertiolicenseagre038.jpg	Edgar Link	pending
aqst-assertiolicenseagre039.jpg	Edgar Link	pending
aqst-assertiolicenseagre040.jpg	Edgar Link	pending
aqst-assertiolicenseagre041.jpg	Edgar Link	pending
aqst-assertiolicenseagre042.jpg	Edgar Link	pending
aqst-assertiolicenseagre043.jpg	Edgar Link	pending
aqst-assertiolicenseagre044.jpg	Edgar Link	pending
aqst-assertiolicenseagre045.jpg	Edgar Link	pending
aqst-assertiolicenseagre046.jpg	Edgar Link	pending
aqst-assertiolicenseagre047.jpg	Edgar Link	pending
aqst-assertiolicenseagre048.jpg	Edgar Link	pending
aqst-assertiolicenseagre049.jpg	Edgar Link	pending
ex231kpmgconsent123122.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
indiviorceaamendment0323.htm	Edgar Link	pending
indiviorceaamendment0323001.jpg	Edgar Link	pending
indiviorceaamendment0323002.jpg	Edgar Link	pending
indiviorceaamendment0323003.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AQST
Aquestive Therapeutics, Inc. Stock $aqst

2023 Q1 Form 10-K Financial Statement

#000162828023010180 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AQST Aquestive Therapeutics, Inc. Stock $aqst

2023 Q1 Form 10-K Financial Statement

#000162828023010180 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AQST
Aquestive Therapeutics, Inc. Stock $aqst